Related Experiment Videos
Distribution studies in CD-1 mice administered [14C]muconaldehyde
Z Zhang1, K Cooper, B D Goldstein
1Joint Graduate Program in Toxicology, Rutgers University/UMDNJ-Robert Wood Johnson Medical School, Piscataway 08855-1179, USA.
Archives of Toxicology
|January 1, 1997
Summary
Trans,trans-muconaldehyde (MUC), a benzene metabolite, was tracked in mice to assess its bone marrow distribution. Intravenous administration led to higher MUC levels in blood and bone marrow compared to intraperitoneal, indicating route-dependent distribution.
Area of Science:
- Toxicology
- Pharmacokinetics
- Biochemistry
Background:
- Trans,trans-muconaldehyde (MUC) is a ring-opened metabolite of benzene.
- MUC is implicated in benzene-induced hematotoxicity.
- Understanding MUC distribution is crucial for benzene toxicity research.
Purpose of the Study:
- To investigate the distribution of [14C]muconaldehyde equivalents in mice.
- To determine if [14C]muconaldehyde reaches the bone marrow.
- To evaluate the impact of administration route on MUC distribution.
Main Methods:
- [14C]muconaldehyde was administered intravenously and intraperitoneally to CD-1 mice.
- Radioactivity levels were measured in bone marrow, blood, liver, lung, kidney, and spleen over 24 hours.
- Pharmacokinetic analysis was performed to determine elimination half-lives.
Main Results:
- 0.044% (i.v.) and 0.018% (i.p.) of the administered dose reached the bone marrow.
- Radioactivity elimination followed biphasic patterns in most organs.
- Significantly higher radioactivity was found in blood and bone marrow after i.v. administration.
Conclusions:
- [14C]muconaldehyde equivalents do reach the bone marrow in mice.
- The route of administration significantly influences the distribution and levels of MUC equivalents.
- These findings contribute to understanding benzene's hematotoxic mechanisms.